Rarely has a book focused in so comprehensive a manner on the treatment of schizophrenia. Contemporary Issues in the Treatment of Schizophrenia covers the spectrum of therapeutic approaches to the disorder -- biological, pharmacological, and psychosocial -- as well as presenting a wealth of new research on the course and outcome of schizophrenia. This volume should be a welcome addition to the libraries of psychiatrists, psychiatric residents, psychologists, and other health professionals working with schizophrenia.
Rezensionen / Stimmen
The book is a thorough, clinically oriented literature review covering the diagnosis and current treatment of schizophrenia as well as shortcomings in our understanding this devastating illness. It goes beyond the sometimes cursory overview presented by general psychiatry textbooks and does a good job in reviewing the research that led to our current knowledge. Doody's Health Sciences Book Review Journal
Sprache
Verlagsort
Verlagsgruppe
American Psychiatric Association Publishing
Zielgruppe
Maße
Gewicht
ISBN-13
978-0-88048-681-1 (9780880486811)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
Christian L. Shriqui, M.D., is Assistant Professor in the Department of Psychiatry at Laval University in Quebec City, Canada. Henry A. Nasrallah, M.D., is Professor and Chairman of the Department of Psychiatry at the Ohio State University in Columbus, Ohio.
Biochemistry, Neuropathology, and Genetics of Schizophrenia. The biochemical basis of schizophrenia. Postmortem brain abnormalities in schizophrenia. The new genetics of schizophrenia. Clinical and Diagnostic Issues in Schizophrenia. The diagnosis of schizophrenia. Conceptual models of the relationship between positive and negative symptoms. Epidemiology of positive and negative symptoms in schizophrenia. Depression in schizophrenia. Diagnostic and treatment issues in late-onset schizophrenia. Neuropsychological function in schizophrenia. Relationship of structural brain changes to antipsychotic drug response in schizophrenia. Gender differences in schizophrenia. Pharmacological Treatments. Standard and novel antipsychotic drugs in schizophrenia. Dopaminergic and serotonergic mechanisms in the action of standard and atypical neuroleptics. Clozapine in treatment-refractory schizophrenia. Drug treatment of negative schizophrenic symptoms. Antipsychotic medication and the long-term course of schizophrenia. Neuroleptic noncompliance in schizophrenia. Clinical use of neuroleptic plasma levels. Do neuroleptic-responsive and neuroleptic-resistant patients have different illnesses? Recent neuroleptic maintenance strategies in the management of schizophrenia. Adjunctive nonneuroleptic agents in treatment-refractory schizophrenia. Neuroleptic-Induced Side Effects. Acute extrapyramidal syndromes. Neuroleptic malignant syndrome. Nonextrapyramidal side effects of typical antipsychotic drugs. Tardive dyskinesia. Tardive psychosis. Psychosocial Treatments. Biopsychosocial factors affecting the course of schizophrenia. Family management of schizophrenia. Psychiatric rehabilitation and case management in schizophrenia. Psychotherapeutic management, social skills training, and vocational rehabilitation in schizophrenia. Quality-of-life issues in medicated schizophrenic patients. Psychosocial treatment of substance abuse in schizophrenic patients. Integrating pharmacological and psychosocial treatments in schizophrenia. Individualizing treatment needs in schizophrenia. Index.
